M Ventures is the strategic corporate venture capital arm of Merck KGaA, Darmstadt, Germany, investing in Biotechnology and Technology. It invests globally in transformational ideas across healthcare, life science, and electronics from its headquarters in Amsterdam.
33% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $39.5M (across 105 rounds with reported amounts).
Portfolio
112
Fund Size
$677M
Top Stage
Series B
Last 12 Mo
11
Team
Vijay Narasimhan
Director of Technology Investments and Partnerships
Emma Johnson
Senior Principal
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
137 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| GGency AI | Series B | $20M | Mar 2026 |
 Theolytics | Unknown | — | Mar 2026 |
 Consio AI | Seed | $3.3M | Jan 2026 |
| CConsio | Seed | $3.3M | Jan 2026 |
 Vizgen | Series C | $48M | Jan 2026 |
 FoRx Therapeutics | Series A | $50M | Dec 2025 |
 Novolinc | Unknown | — | Dec 2025 |
 Artios Pharma | Series D | $115M | Nov 2025 |
| AArtios | Series D | $115M | Nov 2025 |
 FMC | Series C | — | Nov 2025 |
 NRG Therapeutics | Series B | $50M | Sep 2025 |
 ReproNovo | Series A | $65M | May 2025 |
 Stimuler | Seed | $3.8M | Apr 2025 |
 ChEmpower | Series A | $18.7M | Apr 2025 |
 Corvic | Seed | $12M | Apr 2025 |
| CCorvic AI | Seed | $12M | Apr 2025 |
 MemryX | Series B | $44M | Mar 2025 |
 TRIMTECH Therapeutics | Seed | $14M | Mar 2025 |
| HHD | Unknown | $7.8M | Feb 2025 |
| Novolinc | Seed | — | Jan 2025 |
 GAIB | Pre-Seed | $5M | Dec 2024 |
 Kivu Bioscience | Series A | $92M | Oct 2024 |
 Forge Nano | Series A | $10M | Oct 2024 |
 PictorLabs | Series B | $30M | Sep 2024 |
 Pictor Labs | Series B | $30M | Sep 2024 |
Page 1 of 6
Top Co-Investors
Pfizer Ventures17 shared
Sofinnova Partners14 shared
Andera Partners10 shared
SV Health Investors10 shared
IP Group plc10 shared
EQT Life Sciences9 shared
RA Capital Management8 shared
Schroders Capital7 shared
Omega Funds7 shared
Arix Bioscience6 shared
Avidity Partners6 shared
The Invus Group, LLC6 shared
Foothill Ventures6 shared
Novartis Pharma AG5 shared
Octopus Ventures4 shared
Illumina Ventures4 shared
Mirae Asset4 shared
NFX3 shared
Insight Partners3 shared
Lux Capital3 shared
Last updated: 7 September 2026